Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 July 2008, Vol. 112, No. 1, pp. 120-130.
Prepublished online as a Blood First Edition Paper on March 6, 2008; DOI 10.1182/blood-2007-09-114181.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-09-114181v1
112/1/120    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, S. D.
Right arrow Articles by Miceli, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, S. D.
Right arrow Articles by Miceli, M. C.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

Endogenous galectin-1 enforces class I–restricted TCR functional fate decisions in thymocytes

Scot D. Liu1, Chan C. Whiting2, Tamar Tomassian3, Mabel Pang4, Stephanie J. Bissel1, Linda G. Baum4, Valeri V. Mossine5, Françoise Poirier6, Margaret E. Huflejt7, and M. Carrie Miceli1,3

1 Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles; 2 Ingenuity Systems, Partner & Professional Services, Redwood City, CA; 3 Molecular Biology Institute and 4 Department of Pathology and Laboratory Medicine, University of California, Los Angeles; 5 Department of Biochemistry, University of Missouri, Columbia; 6 Institut Jacques Monod, Centre National de la Recherche Scientifique Unité Mixte de Recherche Universities, Paris, France; and 7 GlycoMedical Research Institute, La Jolla, CA

During thymocyte development, the T-cell receptor (TCR) can discriminate major histocompatibility complex (MHC)/peptide ligands over a narrow range of affinities and translate subtle differences into functional fate decisions. How small differences in TCR input are translated into absolute differences in functional output is unclear. We examined the effects of galectin-1 ablation in the context of class-I–restricted thymocyte development. Galectin-1 expression opposed TCR partial agonist-driven positive selection, but promoted TCR agonist-driven negative selection of conventional CD8+ T cells. Galectin-1 expression also promoted TCR agonist-driven CD8{alpha}{alpha} intestinal intraepithelial lymphocytes (IEL) development. Recombinant galectin-1 enhanced TCR binding to agonist/MHC complexes and promoted a negative-selection-signaling signature, reflected in intensified rapid and transient extracellular signal-regulated kinase (ERK) activation. In contrast, galectin-1 expression antagonized ERK activity in thymocytes undergoing positive selection. We propose that galectin-1 aids in discriminating TCR-directed fate decisions by promoting TCR binding to agonist/MHC complexes and enforcing agonist-driven signals, while opposing partial-agonist signals. In this way, galectin-1 widens the distinction between TCR-directed functional fate cues.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Thymocyte-fate decisions: bittersweet new flavor
Guy Werlen
Blood 2008 112: 7-8. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Pang, J. He, P. Johnson, and L. G. Baum
CD45-Mediated Fodrin Cleavage during Galectin-1 T Cell Death Promotes Phagocytic Clearance of Dying Cells
J. Immunol., June 1, 2009; 182(11): 7001 - 7008.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Norambuena, C. Metz, L. Vicuna, A. Silva, E. Pardo, C. Oyanadel, L. Massardo, A. Gonzalez, and A. Soza
Galectin-8 Induces Apoptosis in Jurkat T Cells by Phosphatidic Acid-mediated ERK1/2 Activation Supported by Protein Kinase A Down-regulation
J. Biol. Chem., May 8, 2009; 284(19): 12670 - 12679.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
L. V Norling, M. Perretti, and D. Cooper
Endogenous galectins and the control of the host inflammatory response
J. Endocrinol., May 1, 2009; 201(2): 169 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. D. Liu, T. Tomassian, K. W. Bruhn, J. F. Miller, F. Poirier, and M. C. Miceli
Galectin-1 Tunes TCR Binding and Signal Transduction to Regulate CD8 Burst Size
J. Immunol., May 1, 2009; 182(9): 5283 - 5295.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020